BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 15572661)

  • 1. Negative modulation of androgen receptor transcriptional activity by Daxx.
    Lin DY; Fang HI; Ma AH; Huang YS; Pu YS; Jenster G; Kung HJ; Shih HM
    Mol Cell Biol; 2004 Dec; 24(24):10529-41. PubMed ID: 15572661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of androgen receptor mediated transcription by the ErbB-3 binding protein, Ebp1.
    Zhang Y; Fondell JD; Wang Q; Xia X; Cheng A; Lu ML; Hamburger AW
    Oncogene; 2002 Aug; 21(36):5609-18. PubMed ID: 12165860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells.
    Yuan H; Gong A; Young CY
    Carcinogenesis; 2005 Apr; 26(4):793-801. PubMed ID: 15661808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes.
    Li R; Pei H; Watson DK; Papas TS
    Oncogene; 2000 Feb; 19(6):745-53. PubMed ID: 10698492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daxx mediates the small ubiquitin-like modifier-dependent transcriptional repression of Smad4.
    Chang CC; Lin DY; Fang HI; Chen RH; Shih HM
    J Biol Chem; 2005 Mar; 280(11):10164-73. PubMed ID: 15637079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and identification of L-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid system.
    Wafa LA; Cheng H; Rao MA; Nelson CC; Cox M; Hirst M; Sadowski I; Rennie PS
    Biochem J; 2003 Oct; 375(Pt 2):373-83. PubMed ID: 12864730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical and functional interactions between Daxx and TSG101.
    Muromoto R; Sugiyama K; Yamamoto T; Oritani K; Shimoda K; Matsuda T
    Biochem Biophys Res Commun; 2004 Apr; 316(3):827-33. PubMed ID: 15033475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sterol regulatory element-binding protein-1c represses the transactivation of androgen receptor and androgen-dependent growth of prostatic cells.
    Suh JH; Gong EY; Kim JB; Lee IK; Choi HS; Lee K
    Mol Cancer Res; 2008 Feb; 6(2):314-24. PubMed ID: 18245227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells.
    Gross M; Liu B; Tan J; French FS; Carey M; Shuai K
    Oncogene; 2001 Jun; 20(29):3880-7. PubMed ID: 11439351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daxx positively modulates beta-catenin/TCF4-mediated transcriptional potential.
    Huang YS; Shih HM
    Biochem Biophys Res Commun; 2009 Sep; 386(4):762-8. PubMed ID: 19563778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
    J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
    Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
    Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trihydrophobin 1 attenuates androgen signal transduction through promoting androgen receptor degradation.
    Yang Y; Zou W; Kong X; Wang H; Zong H; Jiang J; Wang Y; Hong Y; Chi Y; Xie J; Gu J
    J Cell Biochem; 2010 Apr; 109(5):1013-24. PubMed ID: 20069563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein inhibitor of activated STAT3 regulates androgen receptor signaling in prostate carcinoma cells.
    Junicho A; Matsuda T; Yamamoto T; Kishi H; Korkmaz K; Saatcioglu F; Fuse H; Muraguchi A
    Biochem Biophys Res Commun; 2000 Nov; 278(1):9-13. PubMed ID: 11071847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The LATS2/KPM tumor suppressor is a negative regulator of the androgen receptor.
    Powzaniuk M; McElwee-Witmer S; Vogel RL; Hayami T; Rutledge SJ; Chen F; Harada S; Schmidt A; Rodan GA; Freedman LP; Bai C
    Mol Endocrinol; 2004 Aug; 18(8):2011-23. PubMed ID: 15131260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and functional characterization of a rat Daxx that functions as a corepressor for the androgen receptor.
    Mizuta H; Kuroda Y
    Cell Biol Int; 2004; 28(8-9):609-14. PubMed ID: 15350595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth.
    Hsu CL; Chen YL; Ting HJ; Lin WJ; Yang Z; Zhang Y; Wang L; Wu CT; Chang HC; Yeh S; Pimplikar SW; Chang C
    Mol Endocrinol; 2005 Feb; 19(2):350-61. PubMed ID: 15514032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of androgen receptor associated coregulators in prostate cancer cells.
    Sampson ER; Yeh SY; Chang HC; Tsai MY; Wang X; Ting HJ; Chang C
    J Biol Regul Homeost Agents; 2001; 15(2):123-9. PubMed ID: 11501969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic activation of the androgen receptor by bombesin and low-dose androgen.
    Dai J; Shen R; Sumitomo M; Stahl R; Navarro D; Gershengorn MC; Nanus DM
    Clin Cancer Res; 2002 Jul; 8(7):2399-405. PubMed ID: 12114445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.